CHD1L and neoplasm: Four recurrent deleterious variants corresponding to the CHD1L (99.0%), GFM1 (91.7%), MEIS1 (90.6%) and NFX1 (93.8%) genes were found in the majority of the tumor samples in the study cohort, but in none of the normal controls.